Evaluation of angiogenesis in non-small cell lung cancer: Comparison between anti-CD34 antibody and anti-CD105 antibody

Clinical Cancer Research

Volumn 7, Issue 11, 2001, Pages 3410-3415

  Tanaka, F ^a   Otake, Y ^a   Yanagihara, K ^a   Kawano, Y ^a   Miyahara, R ^a   Li, M ^a   Yamada, T ^a   Hanaoka, N ^a   Inui, K ^a   Wada, H ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ENDOGLIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD105; MONOCLONAL ANTIBODY CD34; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; COMPARATIVE STUDY; ENDOTHELIUM CELL; EVALUATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR GROWTH;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD34; BLOOD VESSELS; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035179614     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Induction of angiogenesis during the transition from hyperplasia to neoplasia
2. Angiogenesis and non-small cell lung cancer
3. Realation of neovascularization to metastasis of non-small-cell lung cancer
4. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
5. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer
6. Prognostic value of angiogenesis is a significant prognostic marker in operable non small cell lung cancer
7. Relationship between vascularity, age and survival in non-small-cell lung cancer
8. Immunocytochemical markers in stage I lung cancer: Relevance to prognosis
9. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small cell lung cancer
10. CD105 and angiogenesis
11. Quantification of angiogenesis in solid human tumors: An international consensus on the methodology and criteria of evaluation
12. Breast carcinoma: Comparative study of tumor vasculature using two endothelial cell markers
13. Examining the technique of angiogenesis assessment in invasive breast cancer
14. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin
15. Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells
16. Induction of lasting complete regression of performed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies
17. Breast carcinoma: Vascular density determined using CD105 antibody correlates with tumor prognosis
18. Revisions in the international system for lung cancer
19. Histological typing of lung and pleural tumors
20. Prognostic significance of apoptotic index in completely resected non-small cell lung cancer
21. p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer
22. Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer
23. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma
24. Angiogenesis correlates with vascular endothelian growth factor expression but not ki-ras oncogene activation in non-small cell lung carcinoma